(Q42481258)

English

Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.

scientific article published on December 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Antonio La Marca

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

L Ciotta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V De Leo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Galvani

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2951-2958

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10601077%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.12.2951

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42481258&oldid=1571555283"